The operation is structured as a leverage buy-out and consists of the purchase, through the specially formed corporate vehicle Medical-Tech S.p.A., of 100% of the share capital of Burke & Burke and the simultaneous reinvestment by the two selling partners and the management of Burke & Burke in Medical-Tech S.p.A., whereby they will collectively hold a 35% stake.

Investor portal
* required fields